Akebia Therapeutics (AKBA) Earnings
|
Expand Research on AKBA
| Next EPS Date | 7/30/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -13.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$0.04 | N/A | N/A | $50.93M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.03 | -$0.01 | -$0.02 | $53.54M | $54.89M | N/A |  | | Details | |
| 2/26/26 | Q425 | -$0.05 | $0.00 | -$0.05 | $57.62M | $56.18M | N/A | | | Details | |
| 11/10/25 | Q325 | $0.00 | -$0.04 | +$0.04 | $58.76M | $52.06M | N/A | | | Details | |
| 8/7/25 | Q225 | $0.00 | -$0.02 | +$0.02 | $62.47M | $47.64M | N/A | | | Details | |
| 7/31/25 |
Q225 | N/A | -$0.02 | N/A | N/A | $47.64M | N/A | N/A | N/A | ||
| 5/8/25 | Q125 | $0.03 | -$0.05 | +$0.08 | $57.34M | $44.38M | N/A | | | Details | |
| 3/13/25 | Q424 | -$0.10 | -$0.07 | -$0.03 | $46.49M | $49.57M | N/A | | | Details |
